CSPC Pharmaceutical Group Balance Sheet Health
Financial Health criteria checks 5/6
CSPC Pharmaceutical Group has a total shareholder equity of CN¥35.0B and total debt of CN¥450.2M, which brings its debt-to-equity ratio to 1.3%. Its total assets and total liabilities are CN¥46.3B and CN¥11.3B respectively. CSPC Pharmaceutical Group's EBIT is CN¥7.0B making its interest coverage ratio -30. It has cash and short-term investments of CN¥13.8B.
Key information
1.3%
Debt to equity ratio
CN¥450.22m
Debt
Interest coverage ratio | -30x |
Cash | CN¥13.76b |
Equity | CN¥35.02b |
Total liabilities | CN¥11.26b |
Total assets | CN¥46.28b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: CSPC.Y's short term assets (CN¥26.7B) exceed its short term liabilities (CN¥10.2B).
Long Term Liabilities: CSPC.Y's short term assets (CN¥26.7B) exceed its long term liabilities (CN¥1.1B).
Debt to Equity History and Analysis
Debt Level: CSPC.Y has more cash than its total debt.
Reducing Debt: CSPC.Y's debt to equity ratio has increased from 0.6% to 1.3% over the past 5 years.
Debt Coverage: CSPC.Y's debt is well covered by operating cash flow (1041.8%).
Interest Coverage: CSPC.Y earns more interest than it pays, so coverage of interest payments is not a concern.